iShares Global Clean Energy ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? iShares Global Clean Energy ETF trades at $17.28 (market cap $2.27B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 10.9× iShares Global Clean Energy ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Global Clean Energy ETF for 87 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| ICLN | ROIV | |
|---|---|---|
Market Cap | $2.27B | $24.72B |
Volume | 6,845,064 | 6,279,442 |
52-Week High | $23.75 | $41.81 |
52-Week Low | $15.78 | $16.04 |
Typical Hold Time | 87 Days | 1 Days |
Sector | — | Health |
Enterprise Value | — | $20.99B |
Signals from Pluang's Aura AI — not financial advice
ICLN trades at $17.28, down 0.17% with a bearish technical outlook showing 14 sell signals versus 3 buy signals. The ETF faces headwinds from higher volatility and expense ratios compared to traditional energy ETFs, though clean energy benefits from global renewable energy acceleration driven by geopolitical tensions and data center power demand growth.
The fund's broader diversification across 105 global clean energy companies provides exposure to the energy transition theme, but investors face risks from competitive pressure from higher-yielding traditional energy ETFs and significant historical drawdowns of 57.2% that highlight the sector's volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →